Cost-Effective Use of the Protein S Algorithm in Thrombophilia Testing

被引:0
|
作者
Rollins-Raval, Marian A. [1 ]
Mitsios, John, V [2 ]
Marlar, Richard A. [1 ]
机构
[1] Univ New Mexico, Dept Pathol, TriCore Reference Labs, Hlth Sci Ctr, Albuquerque, NM 87131 USA
[2] Siemens Healthcare Diagnost Inc, Tarrytown, NY USA
来源
关键词
PLASMA COAGULATION INHIBITORS; DEFICIENCY; RECOMMENDATIONS; COMMUNICATION; GENOTYPE; SSC;
D O I
10.1093/jalm/jfab175
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: One of the most complex risk factors for the laboratory assessment of thrombophilia is Protein S (PS). The testing algorithm for PS employs the plasma-based assays of free PS antigen, total PS antigen, and PS activity creating a complex diagnostic scheme that can lead to misdiagnosis if incorrectly used, and a potential waste of resources and money. Content: This paper compares the recently published evidence-based algorithm from the International Society for Hemostasis and Thrombosis (ISTH) with several commonly performed nonevidence-based testing schemes, to demonstrate the efficiency of the evidence-based algorithm for diagnostic efficiency with improved patient care and increased cost savings for the laboratory. Summary: Significant savings (31%-60%) can be realized when the evidence-based algorithm is used in place of other testing modalities of initial PS activity testing (31%) or testing with all 3 assays simultaneously (60%). This study utilizing the PS testing evidence-based algorithm as part of a thrombophilia evaluation demonstrates that the appropriate testing methods can be used to limit wasteful practices while achieving the maximum level of information in this time of limited resources and need for increase monetary savings.
引用
收藏
页码:794 / 802
页数:9
相关论文
共 50 条
  • [1] Is screening for thrombophilia cost-effective?
    Wu, Olivia
    Greer, Ian A.
    [J]. CURRENT OPINION IN HEMATOLOGY, 2007, 14 (05) : 500 - 503
  • [2] Using Thrombophilia Testing to Determine Anticoagulation Duration in Pediatric Thrombosis is not Cost-Effective
    O'Brien, Sarah H.
    Smith, Kenneth J.
    [J]. JOURNAL OF PEDIATRICS, 2009, 155 (01): : 100 - 104
  • [3] IS ALLERGY TESTING COST-EFFECTIVE?
    Morris, Adrian
    [J]. CURRENT ALLERGY & CLINICAL IMMUNOLOGY, 2006, 19 (01) : 9 - 12
  • [4] IS PATCH TESTING COST-EFFECTIVE
    RIETSCHEL, RL
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989, 21 (04) : 885 - 887
  • [5] COST-EFFECTIVE LABORATORY TESTING
    BURKE, MD
    [J]. POSTGRADUATE MEDICINE, 1981, 69 (02) : 191 - &
  • [6] IS TUBERCULIN TESTING COST-EFFECTIVE
    LINDENBAUM, JE
    [J]. PEDIATRICS, 1980, 66 (02) : 333 - 334
  • [7] A COST-EFFECTIVE APPROACH TO TESTING
    SHERER, SA
    [J]. IEEE SOFTWARE, 1991, 8 (02) : 34 - 40
  • [8] TPMT testing in azathioprine: a 'cost-effective use of healthcare resources'?
    Payne, Katherine
    Newman, William G.
    Gurwitz, David
    Ibaretta, Dolores
    Phillips, Kathryn A.
    [J]. Personalized Medicine, 2009, 6 (01) : 103 - 113
  • [9] A cost-effective adaptive random testing algorithm for object-oriented software testing
    Zhou, Yue
    Wang, Xiujun
    Guo, Shu
    Wen, Yi
    He, Jingsha
    [J]. JOURNAL OF INTELLIGENT & FUZZY SYSTEMS, 2021, 41 (03) : 4415 - 4423
  • [10] Cost-effective use of antiemetics
    Grunberg, SM
    [J]. ONCOLOGY-NEW YORK, 1998, 12 (03): : 38 - 42